CRISPR (Clustered Regularly Interspaced Palindromic Repeat)/Cas9 System: A Revolutionary Disease-Modifying Technology.

Munshi, Nikhil V

Munshi, Nikhil V.

Afiliação

Munshi NV; From Department of Internal Medicine, Division of Cardiology, UT Southwestern Medical Center; McDermott Center for Human Growth and Development, UT Southwestern Medical Center; Department of Molecular Biology, UT Southwestern Medical Center; and Hamon Center for Regenerative Science and Medicine, UT Southwestern Medical Center; Dallas, TX. Nikhil.Munshi@UTSouthwestern.edu.

Circulation ; 134(11): 777-9, 2016 Sep 13.

Article em En | MEDLINE | ID: mdl-27619714

Assuntos

Sistemas CRISPR-Cas; Doenças Cardiovasculares/terapia; Terapia Genética/métodos; Animais; Doenças Cardiovasculares/genética; Humanos

Palavras-chave

CRISPR; adeno-associated virus; gene therapy; genome; muscular dystrophy, duchenne

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Terapia Genética / Sistemas CRISPR-Cas Limite: Animals / Humans Idioma: En Revista: Circulation Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google